Inappropriate use of digoxin in the elderly: how widespread is the problem and how can it be solved?

Related Experiment Videos

G J Haas1, J B Young

  • 1Section of Heart Failure and Cardiac Transplant Medicine, Department of Cardiology, The Cleveland Clinic Foundation, Ohio 44195, USA. haasg@cesmtp.ccf.org

Drug Safety
|April 30, 1999
PubMed

Insights

Elderly patients often receive digoxin inappropriately for heart failure, increasing toxicity risks. Echocardiography and careful assessment can prevent misuse, ensuring safer cardiovascular medication management.

Area of Science:

  • Gerontology
  • Cardiology
  • Pharmacology

Background:

  • Cardiovascular disease is common in the elderly, necessitating polypharmacy.
  • Digoxin is frequently prescribed for elderly patients with cardiovascular conditions.
  • Adverse effects of medications are more prevalent and pronounced in older adults.

Purpose of the Study:

  • To review the appropriate use of digoxin in the elderly population.
  • To highlight the risks and consequences of inappropriate digoxin administration.
  • To propose strategies for preventing digoxin toxicity in older adults.

Main Methods:

  • Review of current literature on digoxin use in elderly patients.
  • Analysis of potential misdiagnoses leading to inappropriate prescription.
  • Discussion of diagnostic tools and dosage algorithms for safe digoxin use.

Main Results:

  • Inappropriate digoxin use is common in the elderly, often for diastolic heart failure or mimicking conditions.
  • Elderly patients are at high risk for digoxin toxicity.
  • Echocardiography, history, and examination can prevent misinterpretation of clinical findings.

Conclusions:

  • Echocardiography is recommended for suspected congestive heart failure in the elderly to identify appropriate candidates for digoxin.
  • Dosage algorithms considering gender, weight, and creatinine clearance can reduce toxicity risk.
  • Current indications for digoxin include symptomatic heart failure with reduced left ventricular systolic function or atrial fibrillation.

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...